Effects of rosiglitazone on bone in postmenopausal diabetic women
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 06 Jan 2011 Two-year follow-up results have been published (Clinical Endocrinology 73:305-312, 01 Sep 2010)
- 21 Sep 2007 Results reported at EASD 2007.
- 12 Apr 2007 The expected completion date for this trial is now 1 Mar 2006.